Incidence of skin lesions and CLABSI in extremely preterm infants born between 2011 and 2015 in whom 0.5% CHG-70% alc or 0.2% CHG-acetate was used
| Outcome | 0.5% CHG-70% alc (n=41) | 0.2% CHG-acetate (n=41) | p Value |
| Skin lesions | |||
| Eligible for analysis (n) | 41 | 41 | |
| All skin lesions, n (%) | 9 (22%) (95% CI 11% to 37%) | 2 (5%) (95% CI 1% to 15%) | 0.02 |
| Severe skin lesions* | 7 (17%) (95% CI 8% to 31%) | 1 (2%) (95% CI 0% to 11%) | 0.03 |
| Infection | |||
| Eligible for analysis (n) | 29 | 33 | |
| CLABSI, n (%) | 8 (28%) (95% CI 14% to 46%) | 9 (27%) (95% CI 14% to 44%) | 0.98 |
| CLABSI per 1000 catheter days | 15.5 | 15.3 | 0.98 |
| Total indwelling duration, days | 516 | 587 | |
| Total number of central catheters, n | 73 | 77 |
*Severe skin lesions: skin lesion score ≥2.
alc, alcohol; CHG, chlorhexidine gluconate; CLABSI, central line-associated bloodstream infection.